Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity.
O'Callaghan ME, Raymond E, Campbell JM, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K. O'Callaghan ME, et al. Among authors: raymond e. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):318-337. doi: 10.1016/j.ijrobp.2017.02.024. Epub 2017 Feb 21. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463151 Review.
Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity.
O'Callaghan ME, Raymond E, Campbell J, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K. O'Callaghan ME, et al. Among authors: raymond e. Prostate Cancer Prostatic Dis. 2017 Dec;20(4):378-388. doi: 10.1038/pcan.2017.28. Epub 2017 Jun 6. Prostate Cancer Prostatic Dis. 2017. PMID: 28585573 Review.
Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity.
Campbell JM, O'Callaghan ME, Raymond E, Vincent AD, Beckmann KR, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti KL. Campbell JM, et al. Among authors: raymond e. Clin Genitourin Cancer. 2017 Dec;15(6):629-634.e8. doi: 10.1016/j.clgc.2017.03.011. Epub 2017 Mar 30. Clin Genitourin Cancer. 2017. PMID: 28576416 Review.
Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.
Campbell JM, Raymond E, O'Callaghan ME, Vincent AD, Beckmann KR, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti KL. Campbell JM, et al. Among authors: raymond e. Clin Genitourin Cancer. 2017 Oct;15(5):e827-e834. doi: 10.1016/j.clgc.2017.06.001. Epub 2017 Jun 8. Clin Genitourin Cancer. 2017. PMID: 28666689 Review.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. N Engl J Med. 2013 Jan 10;368(2):138-48. doi: 10.1056/NEJMoa1209096. Epub 2012 Dec 10. N Engl J Med. 2013. PMID: 23228172 Free PMC article. Clinical Trial.
Accuracy of Survey-Based Assessment of Eligibility for Medication Abortion Compared to Clinician Assessment.
Ralph LJ, Ehrenreich K, Kaller S, Gurazada T, Biggs MA, Blanchard K, Hauser D, Kapp N, Kromenaker T, Moayedi G, Pinckney Gil J, Perritt JB, Raymond E, Taylor D, White K, Valladares ES, Williams S, Grossman D. Ralph LJ, et al. Among authors: raymond e. Am J Obstet Gynecol. 2025 Jan 9:S0002-9378(25)00013-4. doi: 10.1016/j.ajog.2025.01.008. Online ahead of print. Am J Obstet Gynecol. 2025. PMID: 39798911 Free article.
The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.
Kotwal SS, Perkovic V, Jardine MJ, Kim D, Shah NA, Lin E, Coggan S, Billot L, Vart P, Wheeler DC, de Boer IH, Zhang H, Hou FF, Sugawara Y, Marion J, Lewis RJ, Berry LR, McGlothlin A, Jha V, De Nicola L, Gorriz JL, Heerspink HJL; GKPTN and CAPTIVATE Investigators. Kotwal SS, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2449998. doi: 10.1001/jamanetworkopen.2024.49998. JAMA Netw Open. 2024. PMID: 39661388 Free PMC article.
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors.
Hammel P, Smith D, Afchain P, Dominguez-Tinajero S, Seitz JF, Lievre A, Van Cutsem E, Assenat E, Di Fiore F, Peeters M, Sobhani I, Raymond E, Charton E, Vernerey D, De Mestier L, Lombard-Bohas C. Hammel P, et al. Among authors: raymond e. Ther Adv Med Oncol. 2024 Nov 19;16:17588359241290140. doi: 10.1177/17588359241290140. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39563716 Free PMC article.
600 results